National Cancer Institute (NCI) at ENA 2026
Nov 18–20, 2026 Barcelona, Spain ~1.5k attendees Website
National Cancer Institute (NCI) brings 8 presentations to ENA 2026 in Barcelona. Its program mixes immunotherapy and cell therapy with work on drug resistance and combination treatment. It includes a virus-like drug conjugate for cutaneous melanoma and CRISPR screens comparing two- and three-dimensional ovarian cancer models to find resistance to CHEK1 inhibition.
| Organization | ENA 2026 Attendance |
|---|---|
National Cancer Institute (NCI) Bethesda, Maryland | |
Federal agency within NIH that funds and conducts cancer research, including intramural labs and clinical trials. | Session Wed Nov 18 1:30–1:35pm Poster Wed Nov 18 12–1:30pm 3:50–4:15pm 5:45–7pm Session Thu Nov 19 10–11:30am Session Thu Nov 19 5–6:30pm Poster Thu Nov 19 9:30–10am 1–3pm 4:30–5pm Session Fri Nov 20 8–9:30am Session Fri Nov 20 11:15am–12pm Poster Fri Nov 20 10:45–11:15am 1:30–3pm |
Instantly find 20 buyers from National Cancer Institute (NCI)
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by EORTC, the NCI or the AACR. Submit a correction